Biocon's Insulin facility in Malaysia receives EU GMP Compliance Certificate
Following inspection by EMA in April 2017
Biocon's subsidiary in Malaysia, Biocon Sdn. Bhd., has been issued a certificate of GMP Compliance for its Insulin manufacturing facility by the HPRA (Ireland) as the representative European inspection authority. Biocon's Malaysia facility was inspected by the EMA in April 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content